Will a Push for Market Share Work for Aurora Cannabis Stock?
Investors can’t figure out if it’s dawn or dusk for Aurora Cannabis, and that means a wild ride for the stock.
Investors can’t figure out if it’s dawn or dusk for Aurora Cannabis, and that means a wild ride for the stock.
High times in hard times? Tilray says pot should be seen as a consumer staple rather than an indulgence.
Cannabis stocks have disappointed but the coronavirus lockdown might boost consumer demand.
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet,…
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
It’s too soon to tell what impact COVID-19 will have on legal and medical cannabis companies such as Canada’s Tilray Inc. But analysts will be watching the company’s next earnings report for…
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
While markets have been recovering since mid-March, cannabis stocks as a whole have not kept pace. Tilray shares have performed the best in this time, more than doubling off of their all-time…
Thursday's top analyst upgrades and downgrades included Bed Bath & Beyond, Ciena, DocuSign, eHealth, Faceboook, Netflix, PNC Financial Services, Square, Tilray, Twitter and Zoom Video Communications.
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Can Aurora Cannabis do anything to avoid the same fate as its peers that are circling the drain? Can anything the company does return it to its former glory?
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
Canadian pot grower Tilray has released 11 million shares of common stock that had been subject to a lockup period following the company's merger with its largest holder last September.
Something is moving Tilray stock far higher than other pot stocks. What can account for a 67% one-day jump in the cannabis company's share price?
For an industry that has been crushed since it entered the market, investors have to wonder if the pain is almost over for the cannabis stocks. Aphria may hold some answers.